U.S., EU regulators clear genotyping test kit from Luminex

07/18/2013 | American City Business Journals

Luminex has secured clearance in the U.S. and Europe for its xTAG CYP2D6 tool, a genotyping assay kit used to help predict patients' responses to specific drugs and allow doctors to personalize treatments. The company also applied for FDA review of a kit intended to analyze the effects of medications used to treat ulcers and other conditions.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ